Latham, Cooley Steer $1.5B Tempus Cancer Testing Deal
Chicago-based Tempus AI said Monday it has agreed to acquire cancer diagnostics company Personalis in a deal with an enterprise value of about $1.5 billion, with Latham & Watkins LLP and...To view the full article, register now.
Already a subscriber? Click here to view full article